Authors:
Coustan-Smith, E
Sancho, J
Hancock, ML
Boyett, JM
Behm, FG
Raimondi, SC
Sandlund, JT
Rivera, GK
Rubnitz, JE
Ribeiro, RC
Pui, CH
Campana, D
Citation: E. Coustan-smith et al., Clinical importance of minimal residual disease in childhood acute lymphoblastic leukemia, BLOOD, 96(8), 2000, pp. 2691-2696
Authors:
Gajjar, A
Harrison, PL
Sandlund, JT
Rivera, GK
Ribeiro, RC
Rubnitz, JE
Razzouk, B
Relling, MV
Evans, WE
Boyett, JM
Pui, CH
Citation: A. Gajjar et al., Traumatic lumbar puncture at diagnosis adversely affects outcome in childhood acute lymphoblastic leukemia, BLOOD, 96(10), 2000, pp. 3381-3384
Authors:
Relling, MV
Hancock, ML
Rivera, GK
Sandlund, JT
Ribeiro, RC
Krynetski, EY
Pui, CH
Evans, WE
Citation: Mv. Relling et al., Mercaptopurine therapy intolerance and heterozygosity at the thiopurine S-methyltransferase gene locus, J NAT CANC, 91(23), 1999, pp. 2001-2008
Authors:
Rubnitz, JE
Behm, FG
Wichlan, D
Ryan, C
Sandlund, JT
Ribeiro, RC
Rivera, GK
Hancock, ML
Relling, MV
Evans, WE
Pui, CH
Downing, JR
Citation: Je. Rubnitz et al., Low frequency or TEL-AML1 In relapsed acute lymphoblastic leukemia supports a favorable prognosis for this genetic subgroup, LEUKEMIA, 13(1), 1999, pp. 19-21
Authors:
Pui, CH
Rubnitz, JE
Hancock, ML
Downing, JR
Raimondi, SC
Rivera, GK
Sandlund, JT
Ribeiro, RC
Head, DR
Relling, MV
Evans, WE
Behm, FG
Citation: Ch. Pui et al., Reappraisal of the clinical and biologic significance of myeloid-associated antigen expression in childhood acute lymphoblastic leukemia, J CL ONCOL, 16(12), 1998, pp. 3768-3773